Simvastatin suppresses endotoxin-induced upregulation of toll-like receptors 4 and 2 in vivo

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344(8934):1383–9. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360(9326):7–22. Almog, 2004, Prior statin therapy is associated with a decreased rate of severe sepsis, Circulation, 110, 880, 10.1161/01.CIR.0000138932.17956.F1 Liappis, 2001, The effect of statins on mortality in patients with bacteremia, Clin Infect Dis, 33, 1352, 10.1086/323334 Ascer, 2004, Atorvastatin reduces proinflammatory markers in hypercholesterolemic patients, Atherosclerosis, 177, 161, 10.1016/j.atherosclerosis.2004.07.003 Pleiner, 2004, Simvastatin prevents vascular hyporeactivity during inflammation, Circulation, 110, 3349, 10.1161/01.CIR.0000147774.90396.ED Martin-Ventura, 2005, Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month, Stroke, 36, 1796, 10.1161/01.STR.0000174289.34110.b0 Pahan, 1997, Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages, J Clin Invest, 100, 2671, 10.1172/JCI119812 Steiner, 2005, Simvastatin blunts endotoxin-induced tissue factor in vivo, Circulation, 111, 1841, 10.1161/01.CIR.0000158665.27783.0C Akira, 2001, Toll-like receptors: critical proteins linking innate and acquired immunity, Nat Immunol, 2, 675, 10.1038/90609 Ashida, 2005, Characterization of the expression of TLR2 (toll-like receptor 2) and TLR4 on circulating monocytes in coronary artery disease, J Atheroscler Thromb, 12, 53, 10.5551/jat.12.53 Methe, 2005, Expansion of circulating toll-like receptor 4-positive monocytes in patients with acute coronary syndrome, Circulation, 111, 2654, 10.1161/CIRCULATIONAHA.104.498865 Xu, 2001, Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL, Circulation, 104, 3103, 10.1161/hc5001.100631 Edfeldt, 2002, Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation, Circulation, 105, 1158, 10.1161/circ.105.10.1158 Kiechl, 2002, Toll-like receptor 4 polymorphisms and atherogenesis, N Engl J Med, 347, 185, 10.1056/NEJMoa012673 Boekholdt, 2003, Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events, Circulation, 107, 2416, 10.1161/01.CIR.0000068311.40161.28 Fan, 2003, TLR4 signaling induces TLR2 expression in endothelial cells via neutrophil NADPH oxidase, J Clin Invest, 112, 1234, 10.1172/JCI18696 Faure, 2001, Bacterial lipopolysaccharide and IFN-gamma induce toll-like receptor 2 and toll-like receptor 4 expression in human endothelial cells: role of NF-kappa B activation, J Immunol, 166, 2018, 10.4049/jimmunol.166.3.2018 Wiedermann, 1999, Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck Study, J Am Coll Cardiol, 34, 1975, 10.1016/S0735-1097(99)00448-9 Ohashi, 2000, Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex, J Immunol, 164, 558, 10.4049/jimmunol.164.2.558 Takemoto, 2001, Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors, Arterioscler Thromb Vasc Biol, 21, 1712, 10.1161/hq1101.098486 Kadowaki, 2001, Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens, J Exp Med, 194, 863, 10.1084/jem.194.6.863 Jilma, 1999, Regulation of adhesion molecules during human endotoxemia. No acute effects of aspirin, Am J Respir Crit Care Med, 159, 857, 10.1164/ajrccm.159.3.9805087 Wittebole, 2005, Expression of tumour necrosis factor receptor and toll-like receptor 2 and 4 on peripheral blood leucocytes of human volunteers after endotoxin challenge: a comparison of flow cytometric light scatter and immunofluorescence gating, Clin Exp Immunol, 141, 99, 10.1111/j.1365-2249.2005.02831.x Mirlashari, 2003, Expression and involvement of toll-like receptors (TLR)2, TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis, Med Sci Monit, 9, BR316 Meier, 2003, Toll-like receptor (TLR) 2 and TLR4 are essential for Aspergillus-induced activation of murine macrophages, Cell Microbiol, 5, 561, 10.1046/j.1462-5822.2003.00301.x Branen, 2004, Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout mice, Arterioscler Thromb Vasc Biol, 24, 2137, 10.1161/01.ATV.0000143933.20616.1b Yla-Herttuala, 1991, Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions, Proc Natl Acad Sci USA, 88, 5252, 10.1073/pnas.88.12.5252 Crisby, 2001, Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization, Circulation, 103, 926, 10.1161/01.CIR.103.7.926 Methe, 2005, Statins decrease toll-like receptor 4 expression and downstream signaling in human CD14+ monocytes, Arterioscler Thromb Vasc Biol, 25, 1439, 10.1161/01.ATV.0000168410.44722.86 Kirsch, 2003, Statin effects on cholesterol micro-domains in brain plasma membranes, Biochem Pharmacol, 65, 843, 10.1016/S0006-2952(02)01654-4 Goebel, 2005, Atorvastatin affects interleukin-2 signaling by altering the lipid raft enrichment of the interleukin-2 receptor Beta chain, J Investig Med, 53, 322, 10.2310/6650.2005.53610 Iwasaki, 2004, Toll-like receptor control of the adaptive immune responses, Nat Immunol, 5, 987, 10.1038/ni1112 Muzio, 2000, Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells, J Immunol, 164, 5998, 10.4049/jimmunol.164.11.5998 Sabroe, 2002, Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses, J Immunol, 168, 4701, 10.4049/jimmunol.168.9.4701 Kurt-Jones, 2002, Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils, Blood, 100, 1860, 10.1182/blood.V100.5.1860.h81702001860_1860_1868